• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植中的耐受。

Tolerance in liver transplantation.

机构信息

Collaborative Transplantation Laboratory, Royal Prince Alfred Hospital and the University of Sydney, Australia.

出版信息

Best Pract Res Clin Gastroenterol. 2012 Feb;26(1):73-84. doi: 10.1016/j.bpg.2012.01.003.

DOI:10.1016/j.bpg.2012.01.003
PMID:22482527
Abstract

Operational tolerance (OT) in liver transplant patients occurs much more frequently than OT of other transplanted organs; however the rate of OT varies considerably with the centre and patient population. Rates of OT range from 15% of the total liver transplant (LTX) patient population down to less than 5%. This review examines the reports of liver OT and compares the factors that could contribute to this variation. Multiple factors were examined, including the time from transplantation when weaning of immunosuppression (IS) was commenced, the rapidity of weaning, the contribution of maintenance and induction IS and the patient population transplanted. The approaches that might be used to increase the likelihood of OT are discussed and the approaches to monitoring OT in LTX patients are reviewed.

摘要

肝移植患者的免疫耐受(Operational tolerance,OT)比其他移植器官的免疫耐受更为常见;然而,免疫耐受的发生率因中心和患者人群而异。免疫耐受的发生率从总肝移植(Liver Transplantation,LTX)患者人群的 15%下降到不足 5%。本综述检查了肝免疫耐受的报告,并比较了可能导致这种变化的因素。检查了多个因素,包括开始免疫抑制(Immunosuppression,IS)脱药的时间、脱药的速度、维持和诱导 IS 的贡献以及移植的患者人群。讨论了可能增加免疫耐受可能性的方法,并回顾了监测 LTX 患者免疫耐受的方法。

相似文献

1
Tolerance in liver transplantation.肝移植中的耐受。
Best Pract Res Clin Gastroenterol. 2012 Feb;26(1):73-84. doi: 10.1016/j.bpg.2012.01.003.
2
Hot-topic debate on tolerance: immunosuppression withdrawal.热点话题辩论:免疫抑制药物撤停。
Liver Transpl. 2011 Nov;17 Suppl 3:S69-73. doi: 10.1002/lt.22421.
3
Approaching the promise of operational tolerance in clinical transplantation.临床移植中接近实现免疫耐受的目标。
Transplantation. 2011 May 27;91(10):1065-74. doi: 10.1097/TP.0b013e318215e742.
4
New approaches to immunosuppression in liver transplantation.肝移植中免疫抑制的新方法。
J Gastroenterol Hepatol. 2002 Feb;17(2):116-26. doi: 10.1046/j.1440-1746.2002.02633.x.
5
Stepwise minimization of the immunosuppressive therapy in pediatric liver transplantation. A conceptual approach towards operational tolerance.儿童肝移植中免疫抑制治疗的逐步减量。实现操作性耐受的一种概念性方法。
Acta Gastroenterol Belg. 2005 Jul-Sep;68(3):320-2.
6
[Development of immune tolerance in liver transplantation].[肝移植中免疫耐受的发展]
Gastroenterol Hepatol. 2011 Mar;34(3):155-69. doi: 10.1016/j.gastrohep.2010.11.007. Epub 2011 Mar 3.
7
Immune activation is required for the induction of liver allograft tolerance: implications for immunosuppressive therapy.诱导肝移植耐受需要免疫激活:对免疫抑制治疗的启示。
Liver Transpl. 2001 Mar;7(3):161-72. doi: 10.1053/jlts.2001.22321.
8
Outcomes after complete immunosuppression withdrawal in liver transplant recipients: rejection-free graft tolerance or late acute rejection?肝移植受者完全停用免疫抑制剂后的结局:无排斥反应的移植物耐受还是晚期急性排斥反应?
Can J Gastroenterol. 1998 Sep;12(6):387-9.
9
Role of the hepatic parenchyma in liver transplant tolerance: a paradigm revisited.肝脏实质在肝移植耐受中的作用:一个被重新审视的范例。
Dig Dis. 2011;29(4):391-401. doi: 10.1159/000329802. Epub 2011 Aug 30.
10
An appraisal of tolerance in liver transplantation.肝移植中的耐受性评估。
Am J Transplant. 2006 Aug;6(8):1774-80. doi: 10.1111/j.1600-6143.2006.01396.x.

引用本文的文献

1
New techniques: a roadmap for the development of HCC immunotherapy.新技术:肝癌免疫治疗的发展路线图。
Front Immunol. 2023 Jun 22;14:1121162. doi: 10.3389/fimmu.2023.1121162. eCollection 2023.
2
Induction Phase of Spontaneous Liver Transplant Tolerance.自发性肝移植耐受的诱导阶段。
Front Immunol. 2020 Sep 11;11:1908. doi: 10.3389/fimmu.2020.01908. eCollection 2020.
3
Why some organ allografts are tolerated better than others: new insights for an old question.为什么有些器官同种移植物比其他的更能被接受:一个老问题的新见解。
Curr Opin Organ Transplant. 2019 Feb;24(1):49-57. doi: 10.1097/MOT.0000000000000594.
4
Mechanisms and biomarkers of immune quiescence in kidney transplantation.肾移植中免疫静止的机制与生物标志物
Hum Immunol. 2018 May;79(5):356-361. doi: 10.1016/j.humimm.2018.01.016. Epub 2018 Feb 19.
5
Hepatic stroma-educated regulatory DCs suppress CD8 T cell proliferation in mice.肝脏基质诱导的调节性树突状细胞抑制小鼠CD8 T细胞增殖。
Oncotarget. 2017 Jun 13;8(55):93414-93425. doi: 10.18632/oncotarget.18459. eCollection 2017 Nov 7.
6
Immune monitoring as prerequisite for transplantation tolerance trials.免疫监测作为移植耐受试验的前提条件。
Clin Exp Immunol. 2017 Aug;189(2):158-170. doi: 10.1111/cei.12988. Epub 2017 Jun 23.
7
Old game, new players: Linking classical theories to new trends in transplant immunology.旧游戏,新玩家:将经典理论与移植免疫学新趋势相联系
World J Transplant. 2017 Feb 24;7(1):1-25. doi: 10.5500/wjt.v7.i1.1.
8
The CD8 T-cell response during tolerance induction in liver transplantation.肝移植耐受诱导过程中的CD8 T细胞反应。
Clin Transl Immunology. 2016 Oct 14;5(10):e102. doi: 10.1038/cti.2016.53. eCollection 2016 Oct.
9
Organ-specific differences in achieving tolerance.实现耐受性过程中的器官特异性差异。
Curr Opin Organ Transplant. 2015 Aug;20(4):392-9. doi: 10.1097/MOT.0000000000000206.
10
Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression.三种不同免疫抑制方案用于肝细胞癌肝移植患者的综合比较:无类固醇免疫抑制、诱导免疫抑制和标准免疫抑制。
PLoS One. 2015 Mar 27;10(3):e0120939. doi: 10.1371/journal.pone.0120939. eCollection 2015.